Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 2
1983 1
1985 1
1986 3
1989 3
1990 6
1991 5
1993 2
1994 7
1995 3
1996 1
1997 2
1998 3
1999 1
2000 2
2001 5
2002 1
2003 8
2004 2
2005 4
2006 1
2007 8
2009 7
2010 4
2011 3
2012 6
2013 1
2014 4
2015 1
2016 1
2017 1
2018 1
2019 6
2020 5
2021 9
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Griffin GK, Weirather JL, Roemer MGM, Lipschitz M, Kelley A, Chen PH, Gusenleitner D, Jeter E, Pak C, Gjini E, Chapuy B, Rosenthal MH, Xu J, Chen BJ, Sohani AR, Lovitch SB, Abramson JS, Ishizuka JJ, Kim AI, Jacobson CA, LaCasce AS, Fletcher CD, Neuberg D, Freeman GJ, Hodi FS, Wright K, Ligon AH, Jacobsen ED, Armand P, Shipp MA, Rodig SJ. Griffin GK, et al. Among authors: kim ai. Blood. 2021 Mar 11;137(10):1353-1364. doi: 10.1182/blood.2020006464. Blood. 2021. PMID: 32871584 Free PMC article.
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.
Armand P, Chen YB, Redd RA, Joyce RM, Bsat J, Jeter E, Merryman RW, Coleman KC, Dahi PB, Nieto Y, LaCasce AS, Fisher DC, Ng SY, Odejide OO, Freedman AS, Kim AI, Crombie JL, Jacobson CA, Jacobsen ED, Wong JL, Patel SS, Ritz J, Rodig SJ, Shipp MA, Herrera AF. Armand P, et al. Among authors: kim ai. Blood. 2019 Jul 4;134(1):22-29. doi: 10.1182/blood.2019000215. Epub 2019 Apr 5. Blood. 2019. PMID: 30952672 Free PMC article. Clinical Trial.
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.
Davids MS, Lampson BL, Tyekucheva S, Wang Z, Lowney JC, Pazienza S, Montegaard J, Patterson V, Weinstock M, Crombie JL, Ng SY, Kim AI, Jacobson CA, LaCasce AS, Armand P, Arnason JE, Fisher DC, Brown JR. Davids MS, et al. Among authors: kim ai. Lancet Oncol. 2021 Oct;22(10):1391-1402. doi: 10.1016/S1470-2045(21)00455-1. Epub 2021 Sep 14. Lancet Oncol. 2021. PMID: 34534514 Clinical Trial.
Treatment of hepatitis C.
Kim AI, Saab S. Kim AI, et al. Am J Med. 2005 Aug;118(8):808-15. doi: 10.1016/j.amjmed.2005.01.073. Am J Med. 2005. PMID: 16084169 Review.
Suicide in European Hodgkin Lymphoma Patients.
Kim AI, Goergen H, Engert A, LaCasce AS, Maranda L, Barton B, Borchmann S. Kim AI, et al. Hemasphere. 2019 Feb 22;3(2):e183. doi: 10.1097/HS9.0000000000000183. eCollection 2019 Apr. Hemasphere. 2019. PMID: 31723822 Free PMC article.
Estrogen receptors, antiestrogens, and non-small cell lung cancer.
Bogush TA, Dudko EA, Beme AA, Bogush EA, Kim AI, Polotsky BE, Tjuljandin SA, Davydov MI. Bogush TA, et al. Among authors: kim ai. Biochemistry (Mosc). 2010 Dec;75(12):1421-7. doi: 10.1134/s0006297910120011. Biochemistry (Mosc). 2010. PMID: 21314611 Review.
121 results